Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome

BACKGROUND: Fecal calprotectin (FC) is well accepted as a non-invasive biomarker which objectively reflects colonic inflammation in ulcerative colitis (UC). However, its value as a marker of response during the early phase of remission induction treatment has not been well studied. The aim of this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyonaga, Takahiko, Kobayashi, Taku, Nakano, Masaru, Saito, Eiko, Umeda, Satoko, Okabayashi, Shinji, Ozaki, Ryo, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608360/
https://www.ncbi.nlm.nih.gov/pubmed/28934315
http://dx.doi.org/10.1371/journal.pone.0185131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608360/
https://www.ncbi.nlm.nih.gov/pubmed/28934315
http://dx.doi.org/10.1371/journal.pone.0185131

Ejemplares similares